Novo Nordisk CEO Lars Fruergaard Jørgensen is stepping down as the Danish drug giant faces increased competition for its ...

This month, the Centers for Medicare and Medicaid Services will begin meeting with patients who use the 15 drugs it selected ...

For decades, Americans have been overpaying for prescriptions and subsidizing innovation for the rest of the world. The White ...

What a pity that a Republican administration needs to be reminded that this misguided policy won’t make America healthy or ...

Pharmacy benefit managers face new compensation restrictions and transparency rules from the sweeping reconciliation budget ...

Americans spend more on prescription and over-the-counter drugs than anyone else in the world. It’s true that they take a lot ...

In signing an executive order aimed at reducing U.S. drug prices, President Donald Trump said some prices would be cut in ...

President Donald Trump has now been in office for more than 100 days, and investors certainly have a much more clear picture ...

For the first time in history, Medicare has the power to negotiate the price it pays for some of the costliest and most-used ...

The president has signed an executive order stating that the US will institute a “most-favored-nation” policy, whereby the US will pay the same price for a drug as the nation that pays the lowest ...

Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...

It's no secret that brand-name drugs in the U.S. are much more expensive than they are abroad. In the spirit of fairness, the ...